Biological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc, Takatsuki, Japan.
Laboratory of Animal Physiology and Functional Anatomy, Graduate School of Agriculture, Kyoto University, Kyoto, Japan.
J Diabetes Investig. 2020 Jul;11(4):770-782. doi: 10.1111/jdi.13255. Epub 2020 Apr 16.
Glucose is the most abundant monosaccharide, and an essential source of energy for most living cells. Glucose transport across the cell membrane is mediated by two types of transporters: facilitative glucose transporters (gene name: solute carrier 2A) and sodium-glucose cotransporters (SGLTs; gene name: solute carrier 5A). Each transporter has its own substrate specificity, distribution, and regulatory mechanisms. Recently, SGLT1 and SGLT2 have attracted much attention as therapeutic targets for various diseases. This review addresses the basal and functional properties of glucose transporters and SGLTs, and describes the pharmaceutical potential of SGLT1 and SGLT2.
葡萄糖是最丰富的单糖,也是大多数活细胞的重要能量来源。葡萄糖通过细胞膜的转运是由两种类型的转运蛋白介导的:易化葡萄糖转运蛋白(基因名称:溶质载体 2A)和钠-葡萄糖协同转运蛋白(SGLTs;基因名称:溶质载体 5A)。每种转运蛋白都有其自己的底物特异性、分布和调节机制。最近,SGLT1 和 SGLT2 作为各种疾病的治疗靶点引起了广泛关注。本综述介绍了葡萄糖转运蛋白和 SGLTs 的基本和功能特性,并描述了 SGLT1 和 SGLT2 的药物潜力。